Singapore’s Arista Biotech plans first factory in Hong Kong to meet surging demand for Covid-19 test kits

Arista Biotech, a company that makes Covid-19 testing kits, plans to set up a production facility in Hong Kong, joining the race to tackle a shortage as the city battles a ferocious fifth wave of the pandemic.The Singapore-based company will invest up to HK$60 million (US$7.7 million) in the factory, and plans to sell 10 million Rapid Antigen Test (RAT) kits this year, according to Eric Tang, the co-founder and chief executive for Hong Kong.Arista has not identified a site yet, but hopes to…

Read the original article at South China Morning Post